Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Ali Rabaan and Kuldeep Dhama.
Connection Strength

7.189
  1. Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19. Diagnostics (Basel). 2021 Jun 15; 11(6).
    View in: PubMed
    Score: 0.951
  2. Immunopathogenesis and immunobiology of SARS-CoV-2. Infez Med. 2021 Jun 01; 29(2):167-180.
    View in: PubMed
    Score: 0.948
  3. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens. 2021 May 07; 10(5).
    View in: PubMed
    Score: 0.944
  4. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines (Basel). 2021 Apr 29; 9(5).
    View in: PubMed
    Score: 0.943
  5. COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021 Oct; 49(5):833-853.
    View in: PubMed
    Score: 0.240
  6. COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccin Immunother. 2021 Oct 03; 17(10):3495-3499.
    View in: PubMed
    Score: 0.238
  7. MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges. Ann Clin Microbiol Antimicrob. 2021 Jan 18; 20(1):8.
    View in: PubMed
    Score: 0.231
  8. Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'. Hum Vaccin Immunother. 2020 12 01; 16(12):2888-2890.
    View in: PubMed
    Score: 0.229
  9. Recent advances in vaccine and immunotherapy for COVID-19. Hum Vaccin Immunother. 2020 12 01; 16(12):3011-3022.
    View in: PubMed
    Score: 0.228
  10. Genomic Epidemiology and Recent Update on Nucleic Acid-Based Diagnostics for COVID-19. Curr Trop Med Rep. 2020 Sep 24; 1-7.
    View in: PubMed
    Score: 0.226
  11. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob. 2020 Sep 02; 19(1):40.
    View in: PubMed
    Score: 0.225
  12. SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Med Infect Dis. 2020 Sep - Oct; 37:101830.
    View in: PubMed
    Score: 0.224
  13. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Hum Vaccin Immunother. 2020 12 01; 16(12):2891-2904.
    View in: PubMed
    Score: 0.223
  14. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis. 2020 Sep - Oct; 37:101755.
    View in: PubMed
    Score: 0.221
  15. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview Infez Med. 2020 Ahead Of Print Jun 1; 28(2):174-184.
    View in: PubMed
    Score: 0.215
  16. COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns. Hum Vaccin Immunother. 2021 Nov 02; 17(11):4108-4111.
    View in: PubMed
    Score: 0.060
  17. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies. Hum Vaccin Immunother. 2021 Oct 03; 17(10):3491-3494.
    View in: PubMed
    Score: 0.060
  18. AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal. Travel Med Infect Dis. 2021 Mar-Apr; 40:101989.
    View in: PubMed
    Score: 0.058
  19. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021; 10:40.
    View in: PubMed
    Score: 0.058
  20. Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis. F1000Res. 2021; 10:34.
    View in: PubMed
    Score: 0.058
  21. SARS-CoV-2 reinfection and implications for vaccine development. Hum Vaccin Immunother. 2020 12 01; 16(12):3061-3073.
    View in: PubMed
    Score: 0.057
  22. Impact of COVID-19 on tourism in Nepal. J Travel Med. 2020 09 26; 27(6).
    View in: PubMed
    Score: 0.057
  23. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res. 2020; 9:1107.
    View in: PubMed
    Score: 0.056
  24. Changes in the spatial distribution of COVID-19 incidence in Italy using GIS-based maps. Ann Clin Microbiol Antimicrob. 2020 07 18; 19(1):30.
    View in: PubMed
    Score: 0.056
  25. Mapping the Changes on Incidence, Case Fatality Rates and Recovery Proportion of COVID-19 in Afghanistan Using Geographical Information Systems. Arch Med Res. 2020 08; 51(6):600-602.
    View in: PubMed
    Score: 0.055
  26. MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies. Infez Med. 2020 Jun 01; 28(suppl 1):71-83.
    View in: PubMed
    Score: 0.055
  27. A vaccine is not too far for COVID-19. J Infect Dev Ctries. 2020 May 31; 14(5):450-453.
    View in: PubMed
    Score: 0.055
  28. Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools. Arch Med Res. 2020 07; 51(5):450-452.
    View in: PubMed
    Score: 0.055
  29. Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers. Travel Med Infect Dis. 2020 Mar - Apr; 34:101630.
    View in: PubMed
    Score: 0.054
  30. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar - Apr; 34:101623.
    View in: PubMed
    Score: 0.054
  31. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic. Infez Med. 2020 Ahead of print Jun 1; 28(2):139-142.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.